Regular and Young Investigator Award Abstracts 2022
DOI: 10.1136/jitc-2022-sitc2022.1326
|View full text |Cite
|
Sign up to set email alerts
|

1326 A bifunctional tumor activated immunomodulator (TRACIr) targeting PD-L1 And CD28 Is a potent enhancer of T cell-mediated anti-tumor activity

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles